Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | 55.55 | 93.11 | 125.59 | 147.17 |
| Cost Of Revenue | 172 | 188.72 | 203.62 | 209.75 |
| Gross Profit | -116.45 | -95.61 | -78.02 | -62.57 |
| Operating Expense | 626.01 | 701.30 | 690.20 | 471.59 |
| Operating Income | -742.46 | -796.92 | -768.22 | -534.16 |
| EBITDA | -587.70 | -638.22 | -610.17 | -377.82 |
| EBIT | -742.46 | -796.92 | -768.22 | -534.16 |
| Pretax Income | -5,441.39 | -1,507.64 | -2,162.36 | -534.50 |
| Tax Provision | -42.29 | -41.95 | -135.36 | -126.15 |
| Net Income | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Net Income Common Stockholders | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Total Expenses | 798.01 | 890.02 | 893.82 | 681.34 |
| Interest Income | 1.74 | 7.95 | 26.73 | 28.65 |
| Research And Development | 329.58 | 338.75 | 322.38 | 195.79 |
| Selling General And Administration | 296.44 | 362.56 | 367.82 | 275.80 |
| Normalized EBITDA | 4,112.73 | 80.25 | 810.77 | -349.82 |
| Normalized Income | -735.20 | -767.21 | -695.01 | -386.96 |
| Basic EPS | -173.89 | -47.21 | -63.54 | -11.11 |
| Diluted EPS | -173.89 | -47.21 | -63.54 | -11.11 |
| Tax Effect Of Unusual Items | -36.53 | -19.99 | -88.95 | -6.61 |
| Tax Rate For Calcs | 0.01 | 0.03 | 0.06 | 0.24 |
| Total Unusual Items | -4,700.43 | -718.47 | -1,420.94 | -28 |
| Total Unusual Items Excluding Goodwill | -4,700.43 | -718.47 | -1,420.94 | -28 |
| Net Income From Continuing Operation Net Minority Interest | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Reconciled Depreciation | 154.76 | 158.70 | 158.06 | 156.34 |
| Reconciled Cost Of Revenue | 172 | 188.72 | 203.62 | 209.75 |
| Net Interest Income | 1.74 | 7.95 | 26.73 | 28.65 |
| Net Income From Continuing And Discontinued Operation | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Total Operating Income As Reported | -5,442.89 | -1,515.38 | -2,189.16 | -562.16 |
| Diluted Average Shares | 31.05 | 31.05 | 31.90 | 36.75 |
| Basic Average Shares | 31.05 | 31.05 | 31.90 | 36.75 |
| Diluted NI Availto Com Stockholders | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Net Income Including Noncontrolling Interests | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Net Income Continuous Operations | -5,399.10 | -1,465.68 | -2,027.01 | -408.35 |
| Other Income Expense | -4,700.67 | -718.67 | -1,420.87 | -28.99 |
| Other Non Operating Income Expenses | -0.24 | -0.21 | 0.06 | -0.99 |
| Special Income Charges | -4,700.43 | -718.47 | -1,420.94 | -28 |
| Impairment Of Capital Assets | 4,700.43 | 718.47 | 1,420.94 | 28 |
| Net Non Operating Interest Income Expense | 1.74 | 7.95 | 26.73 | 28.65 |
| Interest Income Non Operating | 1.74 | 7.95 | 26.73 | 28.65 |
| Selling And Marketing Expense | 122.33 | 162.29 | 153.96 | 116.69 |
| General And Administrative Expense | 174.11 | 200.27 | 213.86 | 159.10 |
| Other Gand A | 174.11 | 200.27 | 213.86 | 159.10 |
| Operating Revenue | 55.55 | 93.11 | 125.59 | 147.17 |
